Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pascal Detampel is active.

Publication


Featured researches published by Pascal Detampel.


Scientific Reports | 2015

Activation of NLRP3 inflammasome by crystalline structures via cell surface contact

Aswin Hari; Yifei Zhang; Zhongyuan Tu; Pascal Detampel; Melanie D. Stenner; Anutosh Ganguly; Yan Shi

Crystalline structures activate the NLRP3 inflammasome, leading to the production of IL-1β, however, the molecular interactions responsible for NLRP3 activation are not fully understood. Cathepsin B release from the ruptured phagolysosome and potassium ion efflux have been suggested to be critical for this activation. Here, we report that Cathepsin B redistribution was not a crucial event in crystal-induced IL-1β production. Silica and monosodium urate crystal-treated macrophages with undisturbed lysosomes demonstrated strong co-localization of ASC and Caspase-1, indicative of NLRP3 inflammasome activation. Importantly, we provided evidence to suggest that macrophage cell membrane binding to immobilized crystals was sufficient to induce IL-1β release, and this activation of the NLRP3 inflammasome was inhibited by blocking potassium efflux. Therefore, this work reveals additional complexity in crystalline structure-mediated NLRP3 inflammasome regulations.


Drug Metabolism Reviews | 2012

Drug interaction potential of resveratrol

Pascal Detampel; Mareike Beck; Stephan Krähenbühl; Jörg Huwyler

Resveratrol is a naturally occurring polyphenol that is often used as a food supplement. Many positive health effects, including cardio protection, tumor suppression, and immune modulation, are associated with the intake of resveratrol. Resveratrol is well tolerated in healthy subjects without any comedication. However, supplemental doses of resveratrol in the range of 1 g/day or above by far exceed the natural intake through food. Whether resveratrol-drug interactions can be harmful in patients taking additional medications remains unknown. Recent in vivo studies and clinical trials indicate a possible drug-drug interaction potential using high-dosage formulations. In this review, the known in vitro and in vivo effects of resveratrol on various cytochrome P450 (CYP) isoenzymes are summarized. They are discussed in relation to clinically relevant plasma concentrations in humans. We conclude that resveratrol may lead to interactions with various CYPs, especially when taken in high doses. Aside from systemic CYP inhibition, intestinal interactions must also be considered. They can potentially lead to reduced first-pass metabolism, resulting in higher systemic exposure to certain coadministrated CYP substrates. Therefore, patients who ingest high doses of this food supplement combined with additional medications may be at risk of experiencing clinically relevant drug-drug interactions.


Nature Nanotechnology | 2017

Peptide–MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices

Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; Cesar Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C. W. Chan; Pere Santamaria

We have shown that nanoparticles (NPs) can be used as ligand-multimerization platforms to activate specific cellular receptors in vivo. Nanoparticles coated with autoimmune disease-relevant peptide-major histocompatibility complexes (pMHC) blunted autoimmune responses by triggering the differentiation and expansion of antigen-specific regulatory T cells in vivo. Here, we define the engineering principles impacting biological activity, detail a synthesis process yielding safe and stable compounds, and visualize how these nanomedicines interact with cognate T cells. We find that the triggering properties of pMHC-NPs are a function of pMHC intermolecular distance and involve the sustained assembly of large antigen receptor microclusters on murine and human cognate T cells. These compounds show no off-target toxicity in zebrafish embryos, do not cause haematological, biochemical or histological abnormalities, and are rapidly captured by phagocytes or processed by the hepatobiliary system. This work lays the groundwork for the design of ligand-based NP formulations to re-program in vivo cellular responses using nanotechnology.


Journal of Experimental Medicine | 2017

Strong adhesion by regulatory T cells induces dendritic cell cytoskeletal polarization and contact-dependent lethargy

Jiahuan Chen; Anutosh Ganguly; Ashley D. Mucsi; Junchen Meng; Jiacong Yan; Pascal Detampel; Fay Munro; Zongde Zhang; Mei Wu; Aswin Hari; Melanie D. Stenner; Wencheng Zheng; Paul Kubes; Tie Xia; Matthias Amrein; Hai Qi; Yan Shi

Dendritic cells are targeted by regulatory T (T reg) cells, in a manner that operates as an indirect mode of T cell suppression. In this study, using a combination of single-cell force spectroscopy and structured illumination microscopy, we analyze individual T reg cell–DC interaction events and show that T reg cells exhibit strong intrinsic adhesiveness to DCs. This increased DC adhesion reduces the ability of contacted DCs to engage other antigen-specific cells. We show that this unusually strong LFA-1–dependent adhesiveness of T reg cells is caused in part by their low calpain activities, which normally release integrin–cytoskeleton linkage, and thereby reduce adhesion. Super resolution imaging reveals that such T reg cell adhesion causes sequestration of Fascin-1, an actin-bundling protein essential for immunological synapse formation, and skews Fascin-1–dependent actin polarization in DCs toward the T reg cell adhesion zone. Although it is reversible upon T reg cell disengagement, this sequestration of essential cytoskeletal components causes a lethargic state of DCs, leading to reduced T cell priming. Our results reveal a dynamic cytoskeletal component underlying T reg cell–mediated DC suppression in a contact-dependent manner.


European Journal of Immunology | 2015

Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis

Aswin Hari; Anutosh Ganguly; Libing Mu; Shevaun P. Davis; Melanie D. Stenner; Raymond Lam; Fay Munro; Inana Namet; Tobias Fürstenhaupt; Wei Dong; Pascal Detampel; Lian Jun Shen; Matthias Amrein; Robin M. Yates; Yan Shi

Peptides presented by MHC class I molecules are mostly derived from proteins synthesized by the antigen‐presenting cell itself, while peptides presented by MHC class II molecules are predominantly from materials acquired by endocytosis. External antigens can also be presented by MHC class I molecules in a process referred to as cross‐presentation. Here, we report that mouse dendritic cell (DC) engagement to a phagocytic target alters endocytic processing and inhibits the proteolytic activities. During phagocytosis, endosome maturation is delayed, shows less progression toward the lysosome, and the endocytosed soluble antigen is targeted for MHC class I cross‐presentation. The antigen processing in these arrested endosomes is under the control of NAPDH oxidase associated ROS. We also show that cathepsin S is responsible for the generation of the MHC class I epitope. Taken together, our results suggest that in addition to solid structure uptake, DC phagocytosis simultaneously modifies the kinetics of endosomal trafficking and maturation. As a consequence, external soluble antigens are targeted into the MHC class I cross‐presentation pathway.


International Journal of Nanomedicine | 2014

Polymersomes containing quantum dots for cellular imaging

Marine Camblin; Pascal Detampel; Helene Kettiger; Dalin Wu; Vimalkumar Balasubramanian; Jörg Huwyler

Quantum dots (QDs) are highly fluorescent and stable probes for cellular and molecular imaging. However, poor intracellular delivery, stability, and toxicity of QDs in biological compartments hamper their use in cellular imaging. To overcome these limitations, we developed a simple and effective method to load QDs into polymersomes (Ps) made of poly(dimethylsiloxane)-poly(2-methyloxazoline) (PDMS-PMOXA) diblock copolymers without compromising the characteristics of the QDs. These Ps showed no cellular toxicity and QDs were successfully incorporated into the aqueous compartment of the Ps as confirmed by transmission electron microscopy, fluorescence spectroscopy, and fluorescence correlation spectroscopy. Ps containing QDs showed colloidal stability over a period of 6 weeks if stored in phosphate-buffered saline (PBS) at physiological pH (7.4). Efficient intracellular delivery of Ps containing QDs was achieved in human liver carcinoma cells (HepG2) and was visualized by confocal laser scanning microscopy (CLSM). Ps containing QDs showed a time- and concentration-dependent uptake in HepG2 cells and exhibited better intracellular stability than liposomes. Our results suggest that Ps containing QDs can be used as nanoprobes for cellular imaging.


Journal of Drug Targeting | 2014

Hepatocyte targeting using pegylated asialofetuin-conjugated liposomes

Pascal Detampel; Dominik Witzigmann; Stephan Krähenbühl; Jörg Huwyler

Abstract Background and purpose: The hepatocyte asialoglycoprotein receptor mediates uptake of desiaylated glycoproteins by receptor-mediated endocytosis. This work explores a hepatocyte-specific targeting strategy using asialofetuin (AF) covalently coupled to pegylated liposomes. Methods: AF was conjugated to the distal end of polyethylene glycol–functionalized phospholipids. Chemical modification of AF did not interfere with its receptor interaction. AF-liposomes had a size of less than 130 nm, were judged to be monodisperse and were labelled with fluorescent organic dyes or loaded with quantum dots. Results: In vitro, binding and cellular uptake of fluorescent AF-liposomes by HepG2 hepatocellular carcinoma cells were reduced at low temperature and could be competitively inhibited by an excess of unbound AF. Hepatocyte-specific targeting and internalization of AF-liposomes in vivo was confirmed in the rat and could be competitively inhibited by co-injection of unbound AF. In contrast, non-pegylated liposomes accumulated in cells of the reticuloendothelial system such as hepatic Kupffer cells and spleen after intravenous administration. Conclusion: We conclude that the use of AF-conjugated, pegylated liposomes is a promising strategy to avoid the reticuloendothelial system and specifically target hepatocytes via the asialoglycoprotein receptor in vitro as well as in vivo.


Journal of Controlled Release | 2017

Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo

Sandro Sieber; Philip Grossen; Pascal Detampel; Salome Siegfried; Dominik Witzigmann; Jörg Huwyler

&NA; Nanomedicines have gained much attention for the delivery of small molecules or nucleic acids as treatment options for many diseases. However, the transfer from experimental systems to in vivo applications remains a challenge since it is difficult to assess their circulation behavior in the body at an early stage of drug discovery. Thus, innovative and improved concepts are urgently needed to overcome this issue and to close the gap between empiric nanoparticle design, in vitro assessment, and first in vivo experiments using rodent animal models. This study was focused on the zebrafish as a vertebrate screening model to assess the circulation in blood and extravasation behavior of nanoparticulate drug delivery systems in vivo. To validate this novel approach, monodisperse preparations of fluorescently labeled liposomes with similar size and zeta potential were injected into transgenic zebrafish lines expressing green fluorescent protein in their vasculature. Phosphatidylcholine‐based lipids differed by fatty acid chain length and saturation. Circulation behavior and vascular distribution pattern were evaluated qualitatively and semi‐quantitatively using image analysis. Liposomes composed of lipids with lower transition temperature (<28 °C) as well as PEGylated liposomes showed longer circulation times and extravasation. In contrast, liposomes composed of lipids with transition temperatures > 28 °C bound to venous parts of the vasculature. This circulation patterns in the zebrafish model did correlate with published and experimental pharmacokinetic data from mice and rats. Our findings indicate that the zebrafish model is a useful vertebrate screening tool for nanoparticulate drug delivery systems to predict their in vivo circulation behavior with respect to systemic circulation time and exposure. Graphical abstract Figure. No caption available.


Journal of Pharmaceutical Sciences | 2011

In Vitro Assessment of the Formation of Ceftriaxone–Calcium Precipitates in Human Plasma

Hans-Rudolf Schmutz; Pascal Detampel; Theo Bühler; André Büttler; Benjamin Gygax; Jörg Huwyler

Ceftriaxone is a third-generation cephalosporin antibiotic, which has a broad spectrum of bactericidal activity. Ceftriaxone is highly soluble as a sodium salt, but far less soluble as a calcium salt. Incompatibility of ceftriaxone with calcium and the possible formation of precipitates have been stated in the product label from early on. It was the objective of the present in vitro study to further assess the risk of precipitation of calcium-ceftriaxone in human plasma. Analytical methods were developed (high-performance liquid chromatography and flame atomic absorption spectroscopy) to quantitate calcium and ceftriaxone in human plasma supernatants and human plasma precipitates. Using high concentrations of ceftriaxone (10 mmol/L) and calcium (4.2 mmol/L) did not result in any precipitation after 2 h incubation in human plasma at 37 °C. Under conditions of forced precipitation only, formation of precipitation was observed. The identity of the precipitated material was confirmed by energy-dispersive X-ray analysis and Fourier transform infrared spectroscopy. We conclude that calcium-ceftriaxone in human plasma has an apparent kinetic solubility product constant of greater than 0.42 × 10(-4) (mol/L)(2), which exceeds the normal thermodynamic solubility product in water by a factor of 26. Under these conditions, the formation of plasma precipitates is unlikely.


Biophysical Journal | 2018

Dynamic and Irregular Distribution of RyR2 Clusters in the Periphery of Live Ventricular Myocytes

Florian Hiess; Pascal Detampel; Carme Nolla-Colomer; Alex Vallmitjana; Anutosh Ganguly; Matthias Amrein; Henk E.D.J. ter Keurs; Raul Benitez; Leif Hove-Madsen; S. R. Wayne Chen

Cardiac ryanodine receptors (RyR2s) are Ca2+ release channels clustering in the sarcoplasmic reticulum membrane. These clusters are believed to be the elementary units of Ca2+ release. The distribution of these Ca2+ release units plays a critical role in determining the spatio-temporal profile and stability of sarcoplasmic reticulum Ca2+ release. RyR2 clusters located in the interior of cardiomyocytes are arranged in highly ordered arrays. However, little is known about the distribution and function of RyR2 clusters in the periphery of cardiomyocytes. Here, we used a knock-in mouse model expressing a green fluorescence protein (GFP)-tagged RyR2 to localize RyR2 clusters in live ventricular myocytes by virtue of their GFP fluorescence. Confocal imaging and total internal reflection fluorescence microscopy was employed to determine and compare the distribution of GFP-RyR2 in the interior and periphery of isolated live ventricular myocytes and in intact hearts. We found tightly ordered arrays of GFP-RyR2 clusters in the interior, as previously described. In contrast, irregular distribution of GFP-RyR2 clusters was observed in the periphery. Time-lapse total internal reflection fluorescence imaging revealed dynamic movements of GFP-RyR2 clusters in the periphery, which were affected by external Ca2+ and RyR2 activator (caffeine) and inhibitor (tetracaine), but little detectable movement of GFP-RyR2 clusters in the interior. Furthermore, simultaneous Ca2+- and GFP-imaging demonstrated that peripheral RyR2 clusters with an irregular distribution pattern are functional with a Ca2+ release profile similar to that in the interior. These results indicate that the distribution of RyR2 clusters in the periphery of live ventricular myocytes is irregular and dynamic, which is different from that of RyR2 clusters in the interior.

Collaboration


Dive into the Pascal Detampel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fay Munro

University of Calgary

View shared research outputs
Researchain Logo
Decentralizing Knowledge